A type I interferon signature identifies bilateral striatal necrosis due to mutations in <i>ADAR1</i>

Abstract

ADAR1-related disease should be considered in the differential diagnosis of apparently non-syndromic BSN with severe dystonia of varying evolution. The finding of an interferon signature provides a useful screening test for the presence of ADAR1 mutations in this context, and may suggest novel treatment approaches.